Patterns of bone metastases in newly diagnosed colorectal cancer: a real-world analysis in the SEER database
- 42 Downloads
To investigate the incidence and the associated factors for bone metastases (BM) development and prognosis in initial colorectal cancer (CRC) with a large sample using Surveillance, Epidemiology, and End Results (SEER) cohort.
Primary CRC patients, who were initially diagnosed between 2010 and 2015 in the SEER database, were included to analyze BM incidence and risk factors for BM occurrence. The patients with at least 1-year follow-up were involved to investigate the prognostic factors for BM. Multivariable logistic and proportional hazard regression models were used to investigate the risk factors for BM development and prognosis, respectively.
A total of 212,787 eligible CRC patients were included and 2557 of them were diagnosed with de novo BM (1.20%). Rectal cancer presented significantly higher BM incidence than right and left colon cancer (χ2 = 107.64, P < 0.001). T1 stage, poor differentiated grade, and brain metastases were homogeneously associated factors for BM development and BM patients’ survival. Male gender, higher N stage, rectal site, elevated carcinoembryonic antigen, and lung and liver metastases were positively associated with BM occurrence. Older age, unmarried status, right colon site, and non-surgery were found to positively correlate with the death risk of CRC patients with BM.
BM is rare in CRC patients. Homogeneous and heterogeneous factors were found for BM development and BM patients’ survival. The risk factors and prognostic factors can be used for BM screening and patient’s prognosis estimation.
KeywordsBone metastases Colorectal cancer Risk factor Prognosis factor SEER
The present study was sponsored by the Natural Science Foundation of China (81702161, 81872184, 81801781, and 81602363), the grant of Russian Foundation of Basic Research (15–29-01338), Natural Science Foundation of Tianjin Science and Technology Committee China (17JCQNJC11000), Natural Science Foundation of Tianjin Medical University (2016KYZQ10), and The Doctor Start-up Grant of Tianjin Medical University Cancer Institute and Hospital [B1612, B1711].
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
The present study complied with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards and the study was approved by the Research Ethics Board of the Tianjin Medical University Cancer Institute and Hospital.
The SEER database is an open public database, and the release of data from the SEER database does not require informed patient consent because cancer is a reportable disease in every state of the USA.
- 1.Lyon France: International Agency for Research on Cancer (2013). Available at http://www.globocan.iarc.fr. Accessed 6th July 2018
- 2.Roth ES, Fetzer DT, Barron BJ, Joseph UA, Gayed IW, Wan DQ (2009) Does colon cancer ever metastasize to bone first? A temporal analysis of colorectal cancer progression. BMC Cancer 9:274Google Scholar
- 3.Van Cutsem E, Oliveira J (2009) Advanced colorectal cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 20(Suppl):461–463Google Scholar
- 5.Zhenghong, Zihua Z, Guoweijian, Zhangning, Caiyunyun, Yingjiangshan et al (2017) Retrospective study of predictors of bone metastasis in colorectal cancer patients. J Bone Oncol 9:25–28Google Scholar
- 8.Guo X, Zhang C, Guo Q, Xu Y, Feng G, Li L et al (2018) The homogeneous and heterogeneous risk factors for the morbidity and prognosis of bone metastasis in patients with prostate cancer. Cancer Manag Res 10:1639–1646Google Scholar
- 9.Khattak MA, Martin HL, Beeke C, Price T, Carruthers S, Kim S et al (2012) Survival differences in patients with metastatic colorectal cancer and with single site metastatic disease at initial presentation: results from south Australian clinical registry for advanced colorectal cancer. Clin Colorectal Cancer 11(4):247–254CrossRefGoogle Scholar
- 14.Sun C, Deng Y, Zhou H, Hu ZQ (2015) Risk factors for the development of metachronous bone metastasis in colorectal cancer patients after curative resection. Int J Surg 21:145–149Google Scholar
- 15.Liu F, Zhao J, Xie J, Xie L, Zhu J, Cai S, Zheng H, Xu Y (2016) Prognostic risk factors in patients with bone metastasis from colorectal cancer. In: Tumour Biol, vol 37, pp 16127–16134Google Scholar
- 17.Zhang Y, Guo X, Wang G, Ma W, Liu R, Han X et al (2018) Real-world study of the incidence, risk factors, and prognostic factors associated with bone metastases in women with uterine cervical cancer using Surveillance, Epidemiology, and End Results (SEER) data analysis. Med Sci Monit 24:6387–6397Google Scholar
- 18.Xiong Z, Deng G, Huang X, Li X, Xie X, Wang J et al (2018) Bone metastasis pattern in initial metastatic breast cancer: a population-based study. Cancer Manag Res 10:287–295Google Scholar
- 19.Santini D, Tampellini M, Vincenzi B, Ibrahim T, Ortega C, Virzi V, Silvestris N, Berardi R, Masini C, Calipari N, Ottaviani D, Catalano V, Badalamenti G, Giannicola R, Fabbri F, Venditti O, Fratto ME, Mazzara C, Latiano TP, Bertolini F, Petrelli F, Ottone A, Caroti C, Salvatore L, Falcone A, Giordani P, Addeo R, Aglietta M, Cascinu S, Barni S, Maiello E, Tonini G (2012) Natural history of bone metastasis in colorectal cancer: final results of a large Italian bone metastases study. Ann Oncol 23(8):2072–2077CrossRefGoogle Scholar